Hutch News

Hutch News

Stories tagged 'Michael Jensen'

Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy

Immune-based treatments move from the fringes to the spotlight

June 16, 2017 | By Susan Keown / Fred Hutch News Service

What's new in cancer immunotherapy? Five hot topics, from new combination therapies to cost.

View story >

Replenishing immune cells after remission

New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy

Oct. 17, 2016 | By Bill Briggs / Fred Hutch News Service

Scientists at Fred Hutch, Seattle Children’s Research Institute, and Technical University of Munich showed that activating a “kill switch” can turn off CAR T cells after doctors deem a cancer defeated, allowing normal B cells to again flourish.

View story >

Pediatric cancer specialist speaks Nov. 10

Seattle Children's Michael Jensen will present next Clinical Research Division immunotherapy series lecture 2-3 p.m. in Pelton

Nov. 7, 2011

Dr. Michael Jensen of Seattle Children's will present the next Clinical Research Division Immunotherapy Seminar Series lecture Thursday, Nov. 10, 2-3 p.m. in the Fred Hutchinson Cancer Research Center's Pelton Auditorium .

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.